Zofia Harda, Marta Klimczak, Klaudia Misiołek, Magdalena Chrószcz, Aleksandra Rzeszut, Łukasz Szumiec, Maria Kaczmarczyk-Jarosz, Rafał Ryguła, Barbara Ziółkowska, Jan Rodriguez Parkitna
{"title":"Mu or delta opioid receptor antagonists increase the expression of social conditioned place preference in early adolescent mice.","authors":"Zofia Harda, Marta Klimczak, Klaudia Misiołek, Magdalena Chrószcz, Aleksandra Rzeszut, Łukasz Szumiec, Maria Kaczmarczyk-Jarosz, Rafał Ryguła, Barbara Ziółkowska, Jan Rodriguez Parkitna","doi":"10.1007/s00213-025-06902-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Social behaviors undergo dramatic changes during adolescence, enabling the development of adult social abilities. These changes are intricately linked to the development of the brain reward system and the activity of endogenous opioid signaling. However, the involvement of the opioid system in the development of social behaviors still raises more questions than answers.</p><p><strong>Objectives: </strong>Here, we investigated the role of the endogenous opioid system in the rewarding effects of social contact in early and late adolescent male mice.</p><p><strong>Methods: </strong>Social reward was assessed using the social conditioned place preference task in early adolescent (~ 34 days old) and late adolescent (~ 41 days old) male mice that received a single dose of the selective opioid receptor antagonists cyprodime (1 mg/kg, i.p.), naltrindole (1 mg/kg, i.p.) or norbinaltorphimine (10 mg/kg, i.p.) before the preference posttest.</p><p><strong>Results: </strong>The administration of cyprodime or naltrindole before the posttest significantly increased the preference for the social-conditioned context in early but not late adolescent mice. In contrast, pretreatment with norbinaltorphimine had no effect on context preference.</p><p><strong>Conclusions: </strong>Our findings support a modified version of the state-dependent mu-opioid receptor model of social behavior, where the effects of opioid ligands are not reversed during development but rather weaken or disappear with age. Furthermore, the results indicate that interactions with siblings in early adolescent mice are motivated by negative reinforcement, whereas those in late adolescence are motivated by positive reinforcement.</p>","PeriodicalId":20783,"journal":{"name":"Psychopharmacology","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00213-025-06902-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Rationale: Social behaviors undergo dramatic changes during adolescence, enabling the development of adult social abilities. These changes are intricately linked to the development of the brain reward system and the activity of endogenous opioid signaling. However, the involvement of the opioid system in the development of social behaviors still raises more questions than answers.
Objectives: Here, we investigated the role of the endogenous opioid system in the rewarding effects of social contact in early and late adolescent male mice.
Methods: Social reward was assessed using the social conditioned place preference task in early adolescent (~ 34 days old) and late adolescent (~ 41 days old) male mice that received a single dose of the selective opioid receptor antagonists cyprodime (1 mg/kg, i.p.), naltrindole (1 mg/kg, i.p.) or norbinaltorphimine (10 mg/kg, i.p.) before the preference posttest.
Results: The administration of cyprodime or naltrindole before the posttest significantly increased the preference for the social-conditioned context in early but not late adolescent mice. In contrast, pretreatment with norbinaltorphimine had no effect on context preference.
Conclusions: Our findings support a modified version of the state-dependent mu-opioid receptor model of social behavior, where the effects of opioid ligands are not reversed during development but rather weaken or disappear with age. Furthermore, the results indicate that interactions with siblings in early adolescent mice are motivated by negative reinforcement, whereas those in late adolescence are motivated by positive reinforcement.
期刊介绍:
Official Journal of the European Behavioural Pharmacology Society (EBPS)
Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:
Human Psychopharmacology: Experimental
This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.
Human Psychopharmacology: Clinical and Translational
This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.
Preclinical psychopharmacology: Behavioral and Neural
This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.
Preclinical Psychopharmacology: Translational
This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.
Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic
This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.